May & Baker Nigeria Plc – Medical Sales Representative: I directed to inform the general public about the on-going application at May and Baker Nigeria Plc. May & Baker, Nigeria Plc was founded on September 4, 1944, as Nigeria’s first pharmaceutical company. It has its origin in England, the United Kingdom where in 1834, three chemists founded Grimwade, May & Pickett, a firm for manufacturing chemicals for pharmaceutical products. In 1839 Grimwade, May & Pickett transformed into May & Baker United Kingdom Limited following some changes in the ownership. Use the link below for more information about the application.
May & Baker Nigeria Plc – Medical Sales Representative
May & Baker UK Limited transformed into a mega European conglomerate through a web of mergers and acquisitions over years. Consequently, the name of the company has changed at different times and today, only the Nigerian offshoot is known by the original name.
We are recruiting to fill the position below:
Job Title: Medical Sales Representative
Location: Lagos
Employment Type: Full-time
Responsibilities
- Reporting to the Business Manager, the incumbent will be involved in the promotion of the company’s assigned products to medical and allied professionals in teaching, general, private practice and pharmacies through various levels of marketing interviews/medical meetings to achieve the agreed prescription and sales target.
Requirements
- Candidates must possess a Biological Sciences with at least one (1) year (NYSC inclusive) medical field sales experience with a reputable company.
- Applicants must be result oriented, self-motivated with good oral and written communication skills and must possess strong persuasion and presentation skills with in-depth knowledge of Microsoft Office Suites.
Read more May & Baker Nigeria Plc – Product Specialist
Remuneration
- Attractive and negotiable
How to Apply
Interested and qualified candidates should send CV to: careers@may-bakerng.com using the Job Title as the subject of the mail
Application Deadline 22nd September, 2025.